HighTower Advisors, LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 414 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$1,812,000
-19.5%
39,995
-0.1%
0.00%
-25.0%
Q2 2023$2,250,000
+23.5%
40,031
-0.6%
0.00%0.0%
Q1 2023$1,822,000
+48.0%
40,259
+31.9%
0.00%
+33.3%
Q4 2022$1,231,000
-46.9%
30,512
-13.8%
0.00%
-50.0%
Q3 2022$2,320,000
+12.6%
35,410
+4.2%
0.01%
+20.0%
Q2 2022$2,061,000
-34.1%
33,989
-31.9%
0.01%
-28.6%
Q1 2022$3,129,000
+23.0%
49,883
+49.4%
0.01%
+16.7%
Q4 2021$2,544,000
-47.3%
33,391
-22.6%
0.01%
-53.8%
Q3 2021$4,830,000
-25.7%
43,159
+7.2%
0.01%
-31.6%
Q2 2021$6,498,000
+81.4%
40,253
+36.5%
0.02%
+72.7%
Q1 2021$3,583,000
-11.6%
29,485
+11.4%
0.01%
-35.3%
Q4 2020$4,053,000
+94.2%
26,471
+6.0%
0.02%
+70.0%
Q3 2020$2,087,000
+12.1%
24,974
-1.5%
0.01%0.0%
Q2 2020$1,861,000
+113.2%
25,359
+23.4%
0.01%
+66.7%
Q1 2020$873,000
-22.9%
20,550
+9.9%
0.01%
-14.3%
Q4 2019$1,133,000
+56.9%
18,700
+6.1%
0.01%
+75.0%
Q3 2019$722,000
-32.4%
17,625
-22.2%
0.00%
-33.3%
Q2 2019$1,068,000
+48.1%
22,668
+12.5%
0.01%
+20.0%
Q1 2019$721,000
+50.2%
20,145
+20.7%
0.01%
+25.0%
Q4 2018$480,000
-55.4%
16,692
-31.5%
0.00%
-50.0%
Q3 2018$1,077,000
-5.8%
24,361
+25.3%
0.01%
-11.1%
Q2 2018$1,143,00019,4410.01%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q4 2020
NameSharesValueWeighting ↓
Gilfoyle Management LLC 150$6,37612.96%
Versant Venture Management, LLC 498,558$22,629,54812.03%
NEA Management Company, LLC 1,587,854$72,072,6935.57%
ARK Investment Management 7,163,118$325,133,9132.49%
Nikko Asset Management Americas, Inc. 3,465,470$157,263,0291.88%
Integral Health Asset Management, LLC 275,000$12,482,2501.73%
Merlin Capital, Inc 9,092$412,6861.54%
Del-Sette Capital Management, LLC 33,977$1,542,2161.52%
Green Alpha Advisors, LLC 34,880$1,583,2031.22%
Ikarian Capital, LLC 2,039$9,255,0211.11%
View complete list of CRISPR THERAPEUTICS AG shareholders